The executive branch of the European Union has launched a major project to aggregate cancer imaging data from across the continent so it can be readily tapped by healthcare providers, medical schools and industry innovators.

A 40-year-old man was accompanying his mother to her MRI exam when the magnet caused his gun to fire, shooting him in the abdomen.

The newly approved SGLT2 inhibitor, bexagliflozin, is marketed under the name Brenzavvy. It is not recommended for patients with type 1 diabetes. 

The FDA has declined to accelerate approval of Eli Lilly’s highly anticipated Alzheimer’s drug, but the reason for the rejection may presage a forthcoming thumbs-up.

The American College of Radiology has worked out a way to protect patients from surprise medical bills for out-of-network services while modifying third-party arbitration so it sensibly serves providers and payers alike.  

A study published in the January issue of the Journal of Nuclear Medicine reveals that nearly half of Medicare patients with NSCLC in the United States do not complete recommended FDG PET/CT scans prior to treatment.

The uninsured rate in the United States saw a drop from 11.1% in 2019 to 10.5% in 2021, according to a new report from the Department of Health and Human Services (HHS).

The device, which gained CE mark approval in Europe in May 2021, features a new-look fabric cuff designed to keep the risk of paravalvular leak (PVL) at a minimum.